LINK

Business Context and Reporting Period

Company: Interlink Electronics, Inc. (LINK)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2025
Business Overview: Interlink is a provider of sensors and printed electronics for Human-Machine Interface (HMI) and Internet-of-Things (IoT) solutions. The company operates as a single segment, serving industrial, medical, automotive, consumer, and wearable markets globally. Manufacturing facilities are located in the U.S., China, and the U.K.

Key Financial Metrics

Note: All figures in thousands except per share data and percentages.

Material Changes vs. Prior Period

• Revenue Decline: Revenue decreased 14.7% year-over-year to $2.66 million. This was driven by a 39.7% drop in Medical market revenue and a 91.7% drop in Consumer market revenue, partially offset by a 19.5% increase in Standard product sales.
• Margin Compression: Gross margin declined from 40.1% to 35.6% due to lower revenues and changes in product/customer mix.
• Expense Reduction: Engineering, R&D expenses decreased 24.7% to $434,000, and SG&A expenses decreased 4.5% to $1.36 million, primarily due to reduced headcount and professional services.
• Cash Flow Reversal: Operating cash flow turned negative, using $271,000 in Q1 2025 compared to providing $222,000 in Q1 2024. This was due to the net loss and changes in working capital, despite a reduction in inventory levels.
• Acquisition Impact: The company acquired Conductive Transfers Limited in December 2024 for approximately $314,000. Pro forma revenue for Q1 2025 would have been $2.66 million (unchanged from reported as the acquisition was recent), but pro forma net loss would have been $(805,000).

Guidance, Outlook, and Risks

• Liquidity Position: Management believes existing cash ($2.6 million) is sufficient for current operations. However, $1.9 million of this cash is held by foreign subsidiaries and may incur tax effects if repatriated.
• Preferred Stock Obligations: The company has 200,000 shares of 8.0% Series A Convertible Preferred Stock outstanding with a $5.0 million liquidation preference. Monthly cumulative cash dividends of approximately $100,000 are paid and expected to continue.
• Capital Needs: If circumstances change, the company may need to raise additional capital through equity or debt, which could result in dilution or restrictive covenants.
• Risk Factors: Key risks include customer concentration (two customers accounted for 36% and 11% of receivables), foreign currency fluctuations, supply chain disruptions, and the ability to utilize net operating loss carryforwards (NOLs) due to valuation allowances.
• Related Party Transactions: Significant related party transactions exist with Qualstar Corporation and BKF Capital Group, Inc., involving shared facilities and consulting services.

Investor Verification Checklist

• Cash Burn Rate: Verify the sustainability of operations given the negative operating cash flow of $271,000 and the mandatory $100,000 quarterly preferred dividend obligation.
• Revenue Concentration: Assess the risk associated with the decline in the Medical sector (down 39.7%) and the reliance on specific large customers for accounts receivable.
• Foreign Cash Repatriation: Confirm the tax implications and feasibility of accessing the $1.9 million held in foreign subsidiaries if U.S. liquidity becomes constrained.
• Preferred Stock Conversion: Monitor the conversion price ($8.33) relative to the market price, as the preferred shares are currently anti-dilutive but represent a significant claim on assets ($5.0 million liquidation preference).
• Related Party Dependencies: Review the terms of the facilities sharing and consulting agreements with Qualstar and BKF Capital to ensure arm's-length pricing and operational independence.